Valopicitabine When Administered Alone and in Combination With Interferon to Treatment-Naive Patients With Hepatitis C

NCT00120835 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

INDUSTRY

Sponsor class

Conditions

Chronic Hepatitis C

Interventions

DRUG: valopicitabine
DRUG: pegylated interferon

Sponsor

Merck Sharp & Dohme LLC